FF
If you dig into NaNose Medical you will find out a number of things going back to Brainchip's first engagement with this company dating back to 2020.
1. The initial engagement with Brainchip was for the purpose of analysing the Volatile Organic Compound profile for Covid 19 samples gathered by Chinese researchers on behalf of NaNose Medical (Diagnose at that time) using AKD1000 at the Brainchip Research Centre in Perth Western Australia.
2. It was proven that AKIDA technologies ability to recognise patterns allowed it to excel and if memory now serves me it initially achieved results of greater than 94% accuracy which was State of the Art and as the trials progressed that accuracy increased to again from memory greater than 98%.
3. Brainchip AKIDA technologies since that time has been proven across numerous fields including cyber securityshowing it excels in pattern matching and identification tasks.
4. NaNose Medical was initially spun out of Technion in Israel where the inventor of their nano sensor array Professor Haick was and still is employed.
5. Brainchip partnered with Cornell Tech which in turn is partnered with Technion under the
Technion-Cornell Institute.
6. The purpose of NaNose Medical and Professor Haick has always been to develop a portable non invasive device and prior to successfully partnering with Brainchip had worked for some years with Siemens Medical unsuccessfully to this end. Professor Haick's ultimate ambition was to develop a low cost handheld device to diagnose a range of disease based on samples of breath and the Volatile Organic Compounds contained therein. Professor Haick was aiming for each test to cost between $2.00 to $3.00.
7. In all of the material that is presented on NaNose Medical's current website they refer to their nanoparticle sensors and their algorithm but do not identify the compute upon which the algorithm runs. They do however confirm that they train the nanoparticle sensors to recognise specific VOCs and convert same to electrical impulses that are then interpreted by their algorithm. They do however many times reference pattern matching.
8. This interview from March, 2025 taken from the NaNose Medical website is the most recent information concerning the development of their device:
https://www.linkedin.com/posts/nanose-medical_ilay-marom-of-nanose-medical-activity-7312802439059980288-hSt6/?utm_source=share&utm_medium=member_desktop&rcm=ACoAADbuxfYBCB0Ad15QrKdpKbGWKn9sob5MzLc
It is impossible to say either way whether they are using Brainchip's AKIDA Technology however it would seem strange at least to me that having achieved state of the art performance with Brainchip's technology and that Brainchip's technology has undergone continuous improvement making it even more efficient and intelligent that they would have thrown out something that worked to State of the Art accuracy.
It also seems strange to me again that if they were using something as mainstream as say Nvidia Jetson Nano or an ARM based semiconductor that they would not happily disclose same as their secret sauce is their nanoparticle sensor array and algorithm as I would have expected they would want to crow about how it was portable across any computing technology.
My opinion only DYOR
Fact Finder